BUZZ-Moderna falls on bigger-than-expected loss on weak demand for vaccines

Vaccine maker Moderna's MRNA.O shares fall 2.2% to $31.30 premarket

Co reports Q4 loss of $2.91/share vs analyst est. of loss of $2.68/share, as per data compiled by LSEG

MRNA posts Q4 revenue of $966 million, beating analysts' est. of $942.84 million

Co says the decrease was mostly due to the earlier launch of its updated COVID-19 vaccine in the U.S., which shifted sales into the third quarter, but also due to lower international sales

Stock fell ~67% in the last 12 months